This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Infusion Pumps: Technology And Market 2012-2022

NEW YORK, April 2, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Infusion Pumps: Technology and Market 2012-2022

http://www.reportlinker.com/p0819457/Infusion-Pumps-Technology-and-Market-2012-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

Report Details

Our new report Infusion Pumps: Technology and Market 2012-2022 covers the trends in the infusion pumps market, a promising segment of the drug delivery sector. The traditional gravity controlled infusion pumps have been used extensively. The electronic infusion pumps have also been available in the market since long, but only beginning to see increased adoption. The use of infusion pumps is advantageous for the healthcare providers as well as the patients specifically for conditions such as diabetes, delivery of analgesics in cancer patients or post-surgery, delivery of chemotherapy drugs and enteral feeding in patients with feeding disorders. As the technology becomes more advanced, the infusion pumps are becoming smaller in size, wireless, and more convenient to use. Combined with the ability of the infusion pumps to deliver precisely measured dose are the right intervals, the infusion pumps allow the patients to carry out their normal activities, and reduce the hospital stay and visits. According to our latest pharma report - the global infusion pumps market will be worth $9.5bn by 2016.

Infusion Pumps: Technology and Market 2012-2022 report forecasts the size and value of leading national/regional markets: North America, Europe, Japan, India and China. For each of these, visiongain identifies prevailing trends and strategies that will steer this emerging technology over the forecast period. The use of infusion pumps is still more prevalent in the developed regions of North America and Europe, essentially owing to the fact that the infusion pump technology is expensive when compared to the competing technologies. The cost of insulin pumps is covered under Medicare in the US and through private insurance in Canada. However, there are huge opportunities for infusion pump manufacturers in the developing economies of India and China where the use of electronic infusion pumps is limited at present. The report discusses the future technological development that will make the infusion pumps more attractive to the patients and drive their adoption.

Infusion Pumps: Technology and Market 2012-2022 also examines the challenges facing the sector critically, including the high cost and safety issues. The report is developed through a comprehensive review of information sources, both primary and secondary. In our report you find sales forecasts, growth rates and market shares. You also receive qualitative analyses and a review of companies and leading products.

1 of 11

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,083.80 -2.83 -0.02%
S&P 500 1,987.98 +0.97 0.05%
NASDAQ 4,472.1080 -1.5890 -0.04%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs